25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ILA (Island Pharmaceuticals Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Island Pharmaceuticals Ltd together

I guess you are interested in Island Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Island Pharmaceuticals Ltdโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Island Pharmaceuticals Ltdโ€™s Price Targets

I'm going to help you getting a better view of Island Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Island Pharmaceuticals Ltd

I send you an email if I find something interesting about Island Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Island Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Island Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$0.12
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
A$0.09
Return On Investment
24.0%

For what price can you sell your share?

Current Price per Share
A$0.37
Expected price per share
A$0.24 - A$0.51
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Island Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.37
Intrinsic Value Per Share
A$-0.16 - A$-0.13
Total Value Per Share
A$-0.14 - A$-0.10

2.2. Growth of Island Pharmaceuticals Ltd (5 min.)




Is Island Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$4.6m$989.6k$3.6m78.8%

How much money is Island Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m-$1.8m-$687.9k-26.9%
Net Profit Margin-3,296.7%-228.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Island Pharmaceuticals Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#622 / 844

Most Revenue
#597 / 844

Most Profit
#324 / 844

Most Efficient
#752 / 844
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Island Pharmaceuticals Ltd?

Welcome investor! Island Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Island Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Island Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Island Pharmaceuticals Ltd is A$0.37. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Island Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Island Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Island Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-2.7%-0.01-2.7%-0.01-2.0%-0.01-2.2%-0.01-2.0%-0.01-1.7%
Usd Book Value Change Per Share0.013.9%0.013.9%0.00-0.2%0.000.7%0.001.0%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.013.9%0.013.9%0.00-0.2%0.000.7%0.001.0%0.000.8%
Usd Price Per Share0.11-0.11-0.06-0.10-0.09-0.08-
Price to Earnings Ratio-11.01--11.01--8.42--12.00--12.17--10.14-
Price-to-Total Gains Ratio7.65-7.65--90.46--33.78--33.11--33.11-
Price to Book Ratio6.03-6.03-15.87-16.07-12.64-10.53-
Price-to-Total Gains Ratio7.65-7.65--90.46--33.78--33.11--33.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.241092
Number of shares4147
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (4147 shares)60.0315.24
Gains per Year (4147 shares)240.1260.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1024023006151
204804700122112
307207100183173
409609500244234
50120111900305295
60144114300366356
70168116700427417
80192119100488478
90216121500549539
100240123900610600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%2.04.00.033.3%2.04.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%2.04.00.033.3%2.04.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Island Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0220.0220%-0.001+105%0.004+496%0.006+294%0.005+373%
Book Value Per Share--0.0280.0280%0.006+371%0.014+105%0.017+69%0.014+103%
Current Ratio--22.27322.2730%2.453+808%10.831+106%13.789+62%11.495+94%
Debt To Asset Ratio--0.0450.0450%0.408-89%0.194-77%0.147-69%6.730-99%
Debt To Equity Ratio--0.0470.0470%0.688-93%0.294-84%0.211-78%0.176-73%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--50057542.37050057542.3700%24723545.295+102%41154735.150+22%48095995.876+4%48095995.876+4%
Eps---0.015-0.0150%-0.011-27%-0.013-18%-0.011-27%-0.009-39%
Ev To Sales Ratio--420.970420.9700%19.754+2031%1613.488-74%1613.488-74%1613.488-74%
Free Cash Flow Per Share---0.011-0.0110%-0.012+14%-0.011+4%-0.009-17%-0.008-31%
Free Cash Flow To Equity Per Share--0.0220.0220%-0.001+107%0.003+619%0.005+321%0.009+141%
Gross Profit Margin--1.1771.1770%1.122+5%1.119+5%1.071+10%1.060+11%
Intrinsic Value_10Y_max---0.129----------
Intrinsic Value_10Y_min---0.164----------
Intrinsic Value_1Y_max---0.010----------
Intrinsic Value_1Y_min---0.013----------
Intrinsic Value_3Y_max---0.032----------
Intrinsic Value_3Y_min---0.042----------
Intrinsic Value_5Y_max---0.057----------
Intrinsic Value_5Y_min---0.074----------
Market Cap93897401.570+54%43142049.37043142049.3700%24108792.295+79%38066514.150+13%35782523.301+21%29818769.418+45%
Net Profit Margin---32.967-32.9670%-2.289-93%-97.019+194%-58.212+77%-48.510+47%
Operating Margin----0%-2.2880%-173.0330%-103.8200%-86.5160%
Operating Ratio--46.07546.0750%5.104+803%139.029-67%83.417-45%69.514-34%
Pb Ratio13.120+54%6.0286.0280%15.873-62%16.066-62%12.637-52%10.531-43%
Pe Ratio-23.953-118%-11.005-11.0050%-8.417-24%-12.003+9%-12.167+11%-10.139-8%
Price Per Share0.370+54%0.1700.1700%0.095+79%0.150+13%0.141+21%0.118+45%
Price To Free Cash Flow Ratio-33.918-118%-15.584-15.5840%-7.617-51%-13.511-13%-15.000-4%-12.500-20%
Price To Total Gains Ratio16.655+54%7.6527.6520%-90.456+1282%-33.780+541%-33.109+533%-33.109+533%
Quick Ratio--22.09022.0900%2.440+805%10.723+106%13.596+62%11.334+95%
Return On Assets---0.523-0.5230%-1.117+113%-1.007+93%-0.775+48%-7.097+1256%
Return On Equity---0.548-0.5480%-1.886+244%-1.340+145%-0.991+81%-0.826+51%
Total Gains Per Share--0.0220.0220%-0.001+105%0.004+496%0.006+294%0.005+373%
Usd Book Value--4663241.2124663241.2120%989680.705+371%2272090.321+105%2759922.694+69%2299864.228+103%
Usd Book Value Change Per Share--0.0140.0140%-0.001+105%0.002+496%0.004+294%0.003+373%
Usd Book Value Per Share--0.0180.0180%0.004+371%0.009+105%0.011+69%0.009+103%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--32617494.60832617494.6080%16109862.114+102%26816425.424+22%31339350.913+4%31339350.913+4%
Usd Eps---0.010-0.0100%-0.007-27%-0.008-18%-0.007-27%-0.006-39%
Usd Free Cash Flow---1803866.634-1803866.6340%-2062278.162+14%-1877057.821+4%-1493199.392-17%-1244334.565-31%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.008+14%-0.007+4%-0.006-17%-0.005-31%
Usd Free Cash Flow To Equity Per Share--0.0140.0140%-0.001+107%0.002+619%0.003+321%0.006+141%
Usd Market Cap61183546.863+54%28111359.36928111359.3690%15709289.059+79%24804140.620+13%23315892.183+21%19429910.152+45%
Usd Price Per Share0.241+54%0.1110.1110%0.062+79%0.098+13%0.092+21%0.077+45%
Usd Profit---2554362.572-2554362.5720%-1866389.609-27%-2088357.583-18%-1869902.775-27%-1558323.772-39%
Usd Revenue--77481.75677481.7560%815526.270-90%300072.660-74%180043.596-57%150036.330-48%
Usd Total Gains Per Share--0.0140.0140%-0.001+105%0.002+496%0.004+294%0.003+373%
 EOD+6 -2MRQTTM+0 -0YOY+29 -73Y+29 -75Y+26 -1010Y+27 -9

3.3 Fundamental Score

Let's check the fundamental score of Island Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-23.953
Price to Book Ratio (EOD)Between0-113.120
Net Profit Margin (MRQ)Greater than0-32.967
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than122.090
Current Ratio (MRQ)Greater than122.273
Debt to Asset Ratio (MRQ)Less than10.045
Debt to Equity Ratio (MRQ)Less than10.047
Return on Equity (MRQ)Greater than0.15-0.548
Return on Assets (MRQ)Greater than0.05-0.523
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Island Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.370
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Island Pharmaceuticals Ltd

Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited was founded in 2017 and is based in Camberwell, Australia.

Fundamental data was last updated by Penke on 2025-10-06 07:25:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Island Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • A Net Profit Margin of -3,296.7%ย means thatย $-32.97 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Island Pharmaceuticals Ltd:

  • The MRQ is -3,296.7%. The company is making a huge loss. -2
  • The TTM is -3,296.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,296.7%TTM-3,296.7%0.0%
TTM-3,296.7%YOY-228.9%-3,067.9%
TTM-3,296.7%5Y-5,821.2%+2,524.4%
5Y-5,821.2%10Y-4,851.0%-970.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,296.7%-70.7%-3,226.0%
TTM-3,296.7%-161.7%-3,135.0%
YOY-228.9%-189.8%-39.1%
3Y-9,701.9%-262.6%-9,439.3%
5Y-5,821.2%-338.6%-5,482.6%
10Y-4,851.0%-473.1%-4,377.9%
4.3.1.2. Return on Assets

Shows howย efficientย Island Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • -52.3% Return on Assets means thatย Island Pharmaceuticals Ltd generatedย $-0.52 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Island Pharmaceuticals Ltd:

  • The MRQ is -52.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -52.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-52.3%TTM-52.3%0.0%
TTM-52.3%YOY-111.7%+59.4%
TTM-52.3%5Y-77.5%+25.2%
5Y-77.5%10Y-709.7%+632.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-52.3%-11.9%-40.4%
TTM-52.3%-11.9%-40.4%
YOY-111.7%-11.2%-100.5%
3Y-100.7%-12.0%-88.7%
5Y-77.5%-12.0%-65.5%
10Y-709.7%-14.0%-695.7%
4.3.1.3. Return on Equity

Shows how efficient Island Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • -54.8% Return on Equity means Island Pharmaceuticals Ltd generated $-0.55ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Island Pharmaceuticals Ltd:

  • The MRQ is -54.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -54.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-54.8%TTM-54.8%0.0%
TTM-54.8%YOY-188.6%+133.8%
TTM-54.8%5Y-99.1%+44.3%
5Y-99.1%10Y-82.6%-16.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-54.8%-14.2%-40.6%
TTM-54.8%-14.8%-40.0%
YOY-188.6%-15.3%-173.3%
3Y-134.0%-16.8%-117.2%
5Y-99.1%-17.4%-81.7%
10Y-82.6%-19.8%-62.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Island Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Island Pharmaceuticals Ltd is operatingย .

  • Measures how much profit Island Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • An Operating Margin of 0.0%ย means the company generated $0.00 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-228.8%+228.8%
TTM-5Y-10,382.0%+10,382.0%
5Y-10,382.0%10Y-8,651.6%-1,730.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--153.1%+153.1%
TTM--265.6%+265.6%
YOY-228.8%-249.5%+20.7%
3Y-17,303.3%-248.8%-17,054.5%
5Y-10,382.0%-331.9%-10,050.1%
10Y-8,651.6%-489.0%-8,162.6%
4.3.2.2. Operating Ratio

Measures how efficient Island Pharmaceuticals Ltd is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Biotechnology industry mean).
  • An Operation Ratio of 46.07 means that the operating costs are $46.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 46.075. The company is inefficient in keeping operating costs low. -1
  • The TTM is 46.075. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ46.075TTM46.0750.000
TTM46.075YOY5.104+40.971
TTM46.0755Y83.417-37.343
5Y83.41710Y69.514+13.903
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ46.0751.861+44.214
TTM46.0752.793+43.282
YOY5.1042.852+2.252
3Y139.0293.559+135.470
5Y83.4174.633+78.784
10Y69.5146.269+63.245
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Island Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Biotechnology industry mean).
  • A Current Ratio of 22.27ย means the company has $22.27 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 22.273. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.273. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ22.273TTM22.2730.000
TTM22.273YOY2.453+19.820
TTM22.2735Y13.789+8.483
5Y13.78910Y11.495+2.294
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.2733.431+18.842
TTM22.2733.644+18.629
YOY2.4534.060-1.607
3Y10.8314.456+6.375
5Y13.7895.742+8.047
10Y11.4956.132+5.363
4.4.3.2. Quick Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • A Quick Ratio of 22.09ย means the company can pay off $22.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 22.090. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 22.090. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ22.090TTM22.0900.000
TTM22.090YOY2.440+19.650
TTM22.0905Y13.596+8.494
5Y13.59610Y11.334+2.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.0902.911+19.179
TTM22.0903.133+18.957
YOY2.4403.831-1.391
3Y10.7234.337+6.386
5Y13.5965.697+7.899
10Y11.3346.537+4.797
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Island Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Island Pharmaceuticals Ltdย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Island Pharmaceuticals Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.04ย means that Island Pharmaceuticals Ltd assets areย financed with 4.5% credit (debt) and the remaining percentage (100% - 4.5%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.045. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.045. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.045TTM0.0450.000
TTM0.045YOY0.408-0.363
TTM0.0455Y0.147-0.102
5Y0.14710Y6.730-6.583
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0450.344-0.299
TTM0.0450.364-0.319
YOY0.4080.335+0.073
3Y0.1940.344-0.150
5Y0.1470.349-0.202
10Y6.7300.379+6.351
4.5.4.2. Debt to Equity Ratio

Measures ifย Island Pharmaceuticals Ltd is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • A Debt to Equity ratio of 4.7% means that company has $0.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.047. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.047. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.047TTM0.0470.000
TTM0.047YOY0.688-0.641
TTM0.0475Y0.211-0.164
5Y0.21110Y0.176+0.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0470.401-0.354
TTM0.0470.445-0.398
YOY0.6880.435+0.253
3Y0.2940.471-0.177
5Y0.2110.467-0.256
10Y0.1760.517-0.341
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Island Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced butย always compareย Island Pharmaceuticals Ltd to theย Biotechnology industry mean.
  • A PE ratio of -11.01 means the investor is paying $-11.01ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is -23.953. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.005. Based on the earnings, the company is expensive. -2
  • The TTM is -11.005. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-23.953MRQ-11.005-12.947
MRQ-11.005TTM-11.0050.000
TTM-11.005YOY-8.417-2.588
TTM-11.0055Y-12.167+1.161
5Y-12.16710Y-10.139-2.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-23.953-2.840-21.113
MRQ-11.005-2.312-8.693
TTM-11.005-2.654-8.351
YOY-8.417-3.619-4.798
3Y-12.003-3.736-8.267
5Y-12.167-5.803-6.364
10Y-10.139-6.948-3.191
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is -33.918. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.584. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.584. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.918MRQ-15.584-18.334
MRQ-15.584TTM-15.5840.000
TTM-15.584YOY-7.617-7.967
TTM-15.5845Y-15.000-0.584
5Y-15.00010Y-12.500-2.500
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-33.918-3.555-30.363
MRQ-15.584-2.911-12.673
TTM-15.584-3.693-11.891
YOY-7.617-4.195-3.422
3Y-13.511-5.149-8.362
5Y-15.000-8.425-6.575
10Y-12.500-9.923-2.577
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Island Pharmaceuticals Ltd is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Biotechnology industry mean).
  • A PB ratio of 6.03 means the investor is paying $6.03ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is 13.120. Based on the equity, the company is expensive. -2
  • The MRQ is 6.028. Based on the equity, the company is overpriced. -1
  • The TTM is 6.028. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.120MRQ6.028+7.092
MRQ6.028TTM6.0280.000
TTM6.028YOY15.873-9.845
TTM6.0285Y12.637-6.609
5Y12.63710Y10.531+2.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD13.1202.487+10.633
MRQ6.0282.063+3.965
TTM6.0282.237+3.791
YOY15.8732.444+13.429
3Y16.0662.657+13.409
5Y12.6373.804+8.833
10Y10.5314.517+6.014
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. All numbers in thousands.

Summary
Total Assets7,493
Total Liabilities336
Total Stockholder Equity7,157
 As reported
Total Liabilities 336
Total Stockholder Equity+ 7,157
Total Assets = 7,493

Assets

Total Assets7,493
Total Current Assets7,493
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 7,252
Net Receivables 180
Other Current Assets 62
Total Current Assets  (as reported)7,493
Total Current Assets  (calculated)7,493
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities336
Long-term Liabilities0
Total Stockholder Equity7,157
Total Current Liabilities
Accounts payable 150
Other Current Liabilities 186
Total Current Liabilities  (as reported)336
Total Current Liabilities  (calculated)336
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock31,630
Retained Earnings -25,085
Accumulated Other Comprehensive Income 611
Total Stockholder Equity (as reported)7,157
Total Stockholder Equity (calculated)7,157
+/-0
Other
Cash and Short Term Investments 7,252
Common Stock Shares Outstanding 173,349
Liabilities and Stockholders Equity 7,493
Net Debt -7,252
Net Working Capital 7,157



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
0
6,636
4,899
2,049
2,564
7,493
7,4932,5642,0494,8996,6360
   > Total Current Assets 
0
6,636
4,899
2,049
2,564
7,493
7,4932,5642,0494,8996,6360
       Cash And Cash Equivalents 
0
6,461
4,787
1,998
1,660
7,252
7,2521,6601,9984,7876,4610
       Net Receivables 
0
59
21
17
891
180
1808911721590
   > Long-term Assets 000000
       Other Assets 
0
314
0
0
0
0
00003140
> Total Liabilities 
1
237
581
264
1,046
336
3361,0462645812371
   > Total Current Liabilities 
1
237
581
264
1,046
336
3361,0462645812371
       Short-term Debt 
0
0
0
0
422
0
04220000
       Short Long Term Debt 
0
0
0
0
422
0
04220000
       Accounts payable 
134
82
241
113
312
150
15031211324182134
       Other Current Liabilities 
1
155
340
151
312
186
1863121513401551
   > Long-term Liabilities 000000
       Deferred Long Term Liability 
0
314
0
0
0
0
00003140
> Total Stockholder Equity
-1
6,399
4,318
1,785
1,519
7,157
7,1571,5191,7854,3186,399-1
   Common Stock
0
19,826
19,901
19,901
22,394
31,630
31,63022,39419,90119,90119,8260
   Retained Earnings -25,085-21,200-19,763-4,734-2,127-1
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
0
-11,299
-10,848
1,648
1
0
011,648-10,848-11,2990



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue119
Cost of Revenue-1,405
Gross Profit-1,286-1,286
 
Operating Income (+$)
Gross Profit-1,286
Operating Expense-4,074
Operating Income-5,360-5,360
 
Operating Expense (+$)
Research Development1,405
Selling General Administrative1,974
Selling And Marketing Expenses695
Operating Expense4,0744,074
 
Net Interest Income (+$)
Interest Income0
Interest Expense-27
Other Finance Cost-27
Net Interest Income0
 
Pretax Income (+$)
Operating Income-5,360
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,920-6,800
EBIT - interestExpense = -27
-3,920
-3,893
Interest Expense27
Earnings Before Interest and Taxes (EBIT)0-3,893
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,920
Tax Provision-0
Net Income From Continuing Ops0-3,920
Net Income-3,920
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,479
Total Other Income/Expenses Net1,4400
 

Technical Analysis of Island Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Island Pharmaceuticals Ltd. The general trend of Island Pharmaceuticals Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Island Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Island Pharmaceuticals Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Island Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.455 < 0.51.

The bearish price targets are: 0.28 > 0.24 > 0.24.

Know someone who trades $ILA? Share this with them.๐Ÿ‘‡

Island Pharmaceuticals Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Island Pharmaceuticals Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Island Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartIsland Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Island Pharmaceuticals Ltd. The current adx is .

Island Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartIsland Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Stochastic Oscillator ChartIsland Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartIsland Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartIsland Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Williams %R ChartIsland Pharmaceuticals Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Average True Range (ATR) ChartIsland Pharmaceuticals Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartIsland Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartIsland Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Island Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-10-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Island Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Island Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.370
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Island Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Island Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Island Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Island Pharmaceuticals Ltd

I send you an email if I find something interesting about Island Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Island Pharmaceuticals Ltd.

Receive notifications about Island Pharmaceuticals Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.